27 Part 1

Michael Chen - Part 1: Lessons in Resilience Learned as a Researcher

Michael Chen

‍Part 1 of 2: Jon Chee hosts our latest guest, Michael Chen, the Co-Founder and CEO of Nuclera, a biotech company that focuses on bringing rapid protein access to other labs. Michael is a seasoned scientist and entrepreneur who brings his rich background and insights to our podcast.

Episode artwork for Michael Chen - Part 1: Lessons in Resilience Learned as a Researcher

Show notes

Part 1 of 2: Jon Chee hosts our latest guest, Michael Chen, the Co-Founder and CEO of Nuclera, a biotech company that focuses on bringing rapid protein access to other labs. Michael is a seasoned scientist and entrepreneur who brings his rich background and insights to our podcast.

Before becoming the Co-Founder of Nuclera, Michael did extensive research as an undergrad student at both Georgia tech and Emory and eventually got his Ph,D in Chemistry from the University of Cambridge. Having worked under some of the leading scientists in their field Michael also has 9 scientific publications to his name. His past experiences both at the lab bench and as a CEO make these episodes ones you don’t want to miss.

Join us this week to hear about:

  • The influence of growing up in a data-driven family
  • Learning to do the damn dishes in the lab
  • Getting into the NIH Oxford Cambridge Scholarship Program
  • Learning that what got us here won’t get us to where we need to be
  • Differences between lab work in the UK versus the US

Please enjoy Jon’s conversation with Michael Chen!

Explore the conversation

Continue with the resources, organizations, and people discussed in this episode.

Sources & resources

Primary links are included when they were available in the episode notes.

Companies & people

Michael Chen

About Michael Chen

Michael Chen is the Chief Executive Officer and Co-Founder of Nuclera. In 2013, while working on his PhD at the University of Cambridge, Michael and his co-founders became frustrated by the inaccessibility of proteins to support everything from basic research to drug discovery. This prompted them to found Nuclera, with a clear mission in mind: make proteins more accessible to everyone by providing rapid access to high-quality, soluble, active proteins at the benchtop.

For the past 10 years, Michael has led the company in raising multiple funding rounds totaling $146M. He’s built a team of over 100 people strong over 2 continents and leads the commercial strategy behind bringing their innovative rapid protein prototyping technology to market.

Transcript

Search the conversation or jump directly to a chapter.

Read the full transcript

Don’t Miss Out. Get Episodes in Your Inbox.

Subscribe to the TBSP newsletter to stay up to date on new episodes. Get founder insights and biotech startup stories that show how breakthrough science becomes scalable startups, directly in your inbox.

Peach, the podcast mascot